Urology Research at the Michigan Institute of Urology

 


Bookmark and Share Bookmark and Share


HOUR PROFESSIONALS Magazine Article on the Michigan Institute of Urology
Sat, 21 Nov 2009 12:10:31 MDT
Alphonse Santino, M.D., had more than a brilliant practice model when he founded the Michigan Institute of Urology (MIU) in 1991. He had a vision for providing state-of-the-art treatment for patients seeking urology services.

Almost two decades later, MIU stands alone as the most comprehensive private urology practice in Michigan, with 34 general and fellowship-trained urologists. MIU is consistently recognized locally and nationally as a urology center of excellence, and the practice has 13 convenient office locations that span the metro Detroit area.

As one of the largest subspecialty urology practices in the country, MIU is dedicated to offering patients the highest level of care delivered by specialists recruited from the most prestigious institutions in the United States, including the Cleveland Clinic, Baylor, Sloan-Kettering, and the University of Michigan.

Their hospital affiliations include virtually every Detroit-area health system. Many of MIU's physicians are affiliated with universities and help train the next generation of urologists. Several of them are chiefs of urology within their respective hospitals, and some MIU physicians have served as voting members on the FDA's Urology Device and Immunology panels for a number of years.

Combined patient office visits total more than 12,000 per month, and there are approximately 3,000 new-patient consultations each month. In addition to its team of board-certified urologists, MIU also employs three full-time researchers.

Areas of expertise include virtually every urologic condition, including comprehensive urologic oncology; prostate cancer treatment including cryosurgery, radiation therapy, seed implants, and chemotherapy; treatment of cancer of the bladder and kidneys; treatment of prostate enlargement including medical, surgical, radio frequency ablation, thermotherapy, and laser treatment; medical, surgical, and biofeedback treatment of male and female urinary incontinence including all aspects of urogynecology and neurourology; endourology, including extracorporeal shockwave lithotripsy, ultrasonic lithotripsy, and laser kidney stone removal by both percutaneous and ureteroscopic approaches; minimally invasive surgery including laproscopic prostatectomy, nephrectomy, nephro-ureterectomy, UPJ repair, and pelvic/ retroperitoneal lymph node dissection; management of erectile dysfunction including medical and surgical treatment; management of all male-factor fertility disorders; microsurgical vasectomy reversal; and comprehensive pediatric urology.

MIU's urologists are consistently and repeatedly Hour Detroit "Top Docs" Hall-of-Famers. Whether it's men's health, women's health, or pediatrics, MIU has a full complement of knowledgeable and caring urologists who practice all aspects of adult and pediatric urology. Procedures include minimally invasive surgery for prostate and kidney cancer, robotic surgery for a variety of procedures, and nonsurgical treatment for incontinence and infertility.

Patients know that an MIU physician will provide the most advanced and effective diagnostic and treatment protocol. From prostate cancer to kidney stones to sexual dysfunction, MIU provides the care you need when you need it.

Last year, MIU enhanced its research department to broaden participation in national Phase II, III, and IV clinical trials. This gives MIU patients the opportunity to be exposed to new state-of-the-art therapies sooner than the general public.

Some research studies have included: a Phase II IVe chemotherapeutic treatment for aggressive grades of bladder cancer; a pediatric antibiotic study for complicated urinary tract infection and pyelonephritis; a phase IV drug study for urinary incontinence; Phase III trials for organic erectile dysfunction; a study for patients with new-onset hematuria; a hormonal therapy trial for patients with prostate cancer; Phase III clinical drug trials for psychogenic impotence; interstitial thermotherapy for prostate enlargement; a Phase III clinical drug trial for hormone refractory prostate cancer; Phase IV clinical drug trials for overactive bladders; and a Phase III IVe chemotherapeutic treatment for papillary bladder tumors.

In fact, because of its extensive, highly trained staff — including urologists, nurses, and other medical professionals; its state-of-the art facilities; and its participation in clinical trials and ongoing research, MIU functions much like a university setting, where educating patients about comprehensive urologic care is at the core of its mission.

MIU is also known within the community as being the source for compassionate care and education. This year, the company was a major sponsor of the "Run for the Ribbon," a 5K fundraiser aimed at increasing education and awareness of prostate cancer in southeast Michigan.

For the most comprehensive urologic private care, MIU can be trusted to provide the best treatment available from the most experienced urologists in Michigan.

Its main office is in St. Clair Shores, but MIU also has offices in the following communities: Royal Oak, Commerce, Dearborn, Trenton, West Bloomfield, Utica, Clarkston, Pontiac, Troy, and Rochester Hills.

While MIU has grown in size, keeping patients' needs first remains its most important goal. For Dr. Santino and all the MIU physicians, their practice is more than a vocation; it's a way of ensuring that patient needs are met now, and for years to come. The Michigan institute of ur 20952 East 12 Mile, Ste. 200 St. Clair Shores, MI 48081 586-771-4820

Download the pdf version of this article here.

 

Bookmark and Share Bookmark and Share